SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹18,482,242 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹224 Cr |
| Mar2023 | ₹220 Cr |
| Mar2022 | ₹18,482,242 Cr |
| Mar2017 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 17.45 | |
| Mar2024 | ₹224 Cr | 2.09 | |
| Mar2023 | ₹220 Cr | -100.00 | |
| Mar2022 | ₹18,482,242 Cr | 10,050,222.98 | |
| Mar2017 | ₹184 Cr | - | |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,268.1 Cr | -3.2% | -5.1% | -27.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.2% |
-5.1% |
-27.2% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses